Breaking News
Investing Pro 0
⏰ React to the Market Faster with Custom, Real-Time News Get Started
Close

Sanofi SA (SASY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
95.60 +4.60    +5.05%
09:43:00 - Delayed Data. Currency in EUR ( Disclaimer )
  • Volume: 3,613
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 93.81 - 95.60
Type:  Equity
Market:  Germany
ISIN:  FR0000120578 
S/N:  920657
Sanofi 95.60 +4.60 +5.05%

SASY Financial Summary

 
See below for an overview of the Sanofi SA financial reports. To explore the data further, select a tab to navigate onto a specific report page. Choose to view either annual or quarterly report data.

Sanofi reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was EUR 10,725 million compared to EUR 9,994 million a year ago. Net income was EUR 1,460 million compared to EUR 1,131 million a year ago. Basic earnings per share from continuing operations was EUR 1.16 compared to EUR 0.9 a year ago.For the full year, sales was EUR 42,997 million compared to EUR 37,761 million a year ago. Net income was EUR 6,720 million compared to EUR 6,223 million a year ago. Basic earnings per share from continuing operations was EUR 5.37 compared to EUR 4.97 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

SASY Income Statement

Gross margin TTM 69.83%
Operating margin TTM 24.32%
Net Profit margin TTM 18.44%
Return on Investment TTM 10.23%
 Total Revenue  Net Income
Period Ending: Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Total Revenue 11456 13138 10742 10053
Gross Profit 7722 9307 7492 7173
Operating Income 2134 4652 1980 2573
Net Income 1460 2076 1175 2009

SASY Balance Sheet

Quick Ratio MRQ 0.88
Current Ratio MRQ 1.42
LT Debt to Equity MRQ 19.87%
Total Debt to Equity MRQ 28.36%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Total Assets 124585 121826
Total Liabilities 51073 50522
Total Equity 73512 71304

SASY Cash Flow Statement

Cash Flow/Share TTM 8.39
Revenue/Share TTM 36.19
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of EUR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SASY Comments

Write your thoughts about Sanofi SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Boubacar s b Toure
Boubacar s b Toure Mar 11, 2023 1:51
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nzf
Oct 06, 2022 17:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will eventually do well because of French strategy. France is at the top table and Sanofi was made up by absorbing others to grow. Look at 20% in a couple of years
Greg Greg
Greg Greg Dec 11, 2020 9:36
Saved. See Saved Items.
This comment has already been saved in your Saved Items
there is no future for it
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email